Supplementary Methods from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

Autor:	Juan Manuel Sepúlveda, Pilar Sánchez-Gómez, Aurelio Hernández-Laín, Angel Perez-Nuñez, Diana Cantero, Maria Victoria Bolós, Marta Pajares, Carmen Ramírez-Castillejo, Pilar Aguilera, Cristina Zahonero
Rok vydání:	2023
DOI:	10.1158/1535-7163.22502103.v1
Popis:	Detailed description of methods used in this study.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b2f9c28ce9fd61d5a4c60b91ae88c2 https://doi.org/10.1158/1535-7163.22502103.v1 Zobrazit plný text záznamu